Magnetic Resonance Imaging of Primary Hepatic Malignancies in Patients With and Without Chronic Liver Disease: A Pictorial Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2017 Oct 10

PMID 28989828

Citations 3

Authors

Lauren F Alexander

Peter Harri

Brent Little

Courtney C Moreno

Pardeep K Mittal

Affiliations

Soon will be listed here.

Abstract

Primary hepatic malignancies are less common than metastatic diseases, but a recognition of these lesions is important for diagnosis and treatment planning. Magnetic resonance imaging (MRI) provides the most imaging information to diagnose lesions noninvasively and to narrow differential diagnoses. This paper reviews the imaging findings of chronic liver disease and primary hepatic malignancies, including hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (CCA), epithelioid hemangioendothelioma, hepatic angiosarcoma, and primary hepatic lymphoma. Clinical and MRI features are reviewed to improve the readers' recognition of these tumors, allowing for a narrower differential diagnosis when liver masses are encountered on abdominal imaging.

Citing Articles

Mint3 as a Molecular Target Activated in the Early Stage of Hepatocarcinogenesis.

Nishitani M, Okada H, Nio K, Hayashi T, Terashima T, Iida N Int J Mol Sci. 2025; 26(4).

PMID: 40003897 PMC: 11855386. DOI: 10.3390/ijms26041430.

Advanced diffuse hepatic angiosarcoma treated successfully with TACE and targeted immunotherapy: A case report.

Lin Y, Chen Z, Yang J, Lin Y, Chen S, Xie Y Front Oncol. 2023; 13:1071403.

PMID: 37152029 PMC: 10157244. DOI: 10.3389/fonc.2023.1071403.

Imaging mimickers of cholangiocarcinoma: a pictorial review.

Chiow S, Khoo H, Low J, Tan C, Low H Abdom Radiol (NY). 2022; 47(3):981-997.

PMID: 34978593 DOI: 10.1007/s00261-021-03399-9.

Diagnostic and prognostic value of microRNAs in cholangiocarcinoma: a systematic review and meta-analysis.

Sun C, Zhu J, Wu B, Chen J, Zhu Z, Cai P Cancer Manag Res. 2018; 10:2125-2139.

PMID: 30050323 PMC: 6055881. DOI: 10.2147/CMAR.S158155.

References

Bruix J, Sherman M . Management of hepatocellular carcinoma: an update. Hepatology. 2011; 53(3):1020-2. PMC: 3084991. DOI: 10.1002/hep.24199. View

Soulez G, Bloomgarden D, Rofsky N, Smith M, Abujudeh H, Morgan D . Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol. AJR Am J Roentgenol. 2015; 205(3):469-78. DOI: 10.2214/AJR.14.14268. View

Olnes M, Erlich R . A review and update on cholangiocarcinoma. Oncology. 2004; 66(3):167-79. DOI: 10.1159/000077991. View

Forner A, Reig M, Rodriguez de Lope C, Bruix J . Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis. 2010; 30(1):61-74. DOI: 10.1055/s-0030-1247133. View

Kabbach G, Assi H, Bolotin G, Schuster M, Lee H, Tadros M . Hepatobiliary Tumors: Update on Diagnosis and Management. J Clin Transl Hepatol. 2015; 3(3):169-81. PMC: 4663198. DOI: 10.14218/JCTH.2015.00012. View

Llovet J, Bru C, Bruix J . Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999; 19(3):329-38. DOI: 10.1055/s-2007-1007122. View

Fowler K, Sheybani A, Parker 3rd R, Doherty S, Brunt E, Chapman W . Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol. 2013; 201(2):332-9. DOI: 10.2214/AJR.12.9488. View

Nandwana S, Moreno C, Osipow M, Sekhar A, Cox K . Gadobenate Dimeglumine Administration and Nephrogenic Systemic Fibrosis: Is There a Real Risk in Patients with Impaired Renal Function?. Radiology. 2015; 276(3):741-7. DOI: 10.1148/radiol.2015142423. View

Choi K, Moon W . Epithelioid hemangioendothelioma of the liver. Clin Mol Hepatol. 2013; 19(3):315-9. PMC: 3796683. DOI: 10.3350/cmh.2013.19.3.315. View

10.

Bashir M, Hussain H . Imaging in Patients with Cirrhosis: Current Evidence. Radiol Clin North Am. 2015; 53(5):919-31. DOI: 10.1016/j.rcl.2015.05.006. View

11.

Buetow P, Buck J, Ros P, Goodman Z . Malignant vascular tumors of the liver: radiologic-pathologic correlation. Radiographics. 1994; 14(1):153-66; quiz 167-8. DOI: 10.1148/radiographics.14.1.8128048. View

12.

Tan Y, Xiao E . Rare hepatic malignant tumors: dynamic CT, MRI, and clinicopathologic features: with analysis of 54 cases and review of the literature. Abdom Imaging. 2012; 38(3):511-26. DOI: 10.1007/s00261-012-9918-y. View

13.

Esnaola N, Meyer J, Karachristos A, Maranki J, Camp E, Denlinger C . Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma. Cancer. 2016; 122(9):1349-69. DOI: 10.1002/cncr.29692. View

14.

Choi J, Lee J, Sirlin C . CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology. 2014; 273(1):30-50. PMC: 4263770. DOI: 10.1148/radiol.14132362. View

15.

Kneuertz P, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J . Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol. 2012; 19(9):2897-907. PMC: 3538368. DOI: 10.1245/s10434-012-2336-0. View

16.

Ugurluer G, Miller R, Li Y, Thariat J, Ghadjar P, Schick U . Primary Hepatic Lymphoma: A Retrospective, Multicenter Rare Cancer Network Study. Rare Tumors. 2016; 8(3):6502. PMC: 5064304. DOI: 10.4081/rt.2016.6502. View

17.

Llovet J, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc J . Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008; 359(4):378-90. DOI: 10.1056/NEJMoa0708857. View

18.

Nakajima T, Kondo Y, Miyazaki M, Okui K . A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol. 1988; 19(10):1228-34. DOI: 10.1016/s0046-8177(88)80156-4. View

19.

Shanbhogue A, Prasad S, Takahashi N, Vikram R, Sahani D . Recent advances in cytogenetics and molecular biology of adult hepatocellular tumors: implications for imaging and management. Radiology. 2011; 258(3):673-93. DOI: 10.1148/radiol.10100376. View

20.

Abe H, Kamimura K, Kawai H, Kamimura H, Domori K, Kobayashi Y . Diagnostic imaging of hepatic lymphoma. Clin Res Hepatol Gastroenterol. 2014; 39(4):435-42. DOI: 10.1016/j.clinre.2014.11.001. View